Tyers Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $348K | Hold |
5,611
| – | – | 0.01% | 571 |
|
|
2019
Q2 | $400K | Buy |
5,611
+539
| +11% | +$38.4K | 0.01% | 536 |
|
|
2019
Q1 | $398K | Hold |
5,072
| – | – | 0.01% | 529 |
|
|
2018
Q4 | $429K | Hold |
5,072
| – | – | 0.02% | 451 |
|
|
2018
Q3 | $869K | Buy |
5,072
+135
| +3% | +$23.1K | 0.03% | 326 |
|
|
2018
Q2 | $638K | Hold |
4,937
| – | – | 0.02% | 385 |
|
|
2018
Q1 | $509K | Hold |
4,937
| – | – | 0.02% | 409 |
|
|
2017
Q4 | $422K | Buy |
4,937
+1,077
| +28% | +$92.1K | 0.01% | 474 |
|
|
2017
Q3 | $328K | Buy |
3,860
+763
| +25% | +$64.8K | 0.01% | 505 |
|
|
2017
Q2 | $235K | Buy |
3,097
+1,436
| +86% | +$109K | 0.01% | 570 |
|
|
2017
Q1 | $110K | Buy |
1,661
+314
| +23% | +$20.8K | ﹤0.01% | 646 |
|
|
2016
Q4 | $85K | Buy |
+1,347
| New | +$85K | ﹤0.01% | 679 |
|